Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Nucl Cardiol. 2007 Apr;14(2):207–214. doi: 10.1016/j.nuclcard.2006.12.328

Figure 5.

Figure 5

Quantitative 123I-MIBG uptake in the basal IVS, papillary muscle, and apical levels. At the apex, there were significantly reduced counts in the control and TMR-treated regions compared to the basal IVS. At both the papillary muscle and apical levels, the treated region had significantly lower uptake when compared to the control region.